These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19321784)

  • 1. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
    Sobrado M; Pereira MP; Ballesteros I; Hurtado O; Fernández-López D; Pradillo JM; Caso JR; Vivancos J; Nombela F; Serena J; Lizasoain I; Moro MA
    J Neurosci; 2009 Mar; 29(12):3875-84. PubMed ID: 19321784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.
    Ballesteros I; Cuartero MI; Pradillo JM; de la Parra J; Pérez-Ruiz A; Corbí A; Ricote M; Hamilton JA; Sobrado M; Vivancos J; Nombela F; Lizasoain I; Moro MA
    J Leukoc Biol; 2014 Apr; 95(4):587-98. PubMed ID: 24338629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.
    Cuartero MI; Ballesteros I; Moraga A; Nombela F; Vivancos J; Hamilton JA; Corbí ÁL; Lizasoain I; Moro MA
    Stroke; 2013 Dec; 44(12):3498-508. PubMed ID: 24135932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury.
    Wu L; Miao S; Zou LB; Wu P; Hao H; Tang K; Zeng P; Xiong J; Li HH; Wu Q; Cai L; Ye DY
    J Mol Neurosci; 2012 Sep; 48(1):185-200. PubMed ID: 22661361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
    Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
    Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production.
    Ye Y; Lin Y; Perez-Polo JR; Uretsky BF; Ye Z; Tieu BC; Birnbaum Y
    J Immunol; 2008 Sep; 181(5):3515-23. PubMed ID: 18714024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia.
    Zhao X; Strong R; Zhang J; Sun G; Tsien JZ; Cui Z; Grotta JC; Aronowski J
    J Neurosci; 2009 May; 29(19):6186-95. PubMed ID: 19439596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.
    Pereira MP; Hurtado O; Cárdenas A; Boscá L; Castillo J; Dávalos A; Vivancos J; Serena J; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):218-29. PubMed ID: 16034372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
    Martin HL; Mounsey RB; Mustafa S; Sathe K; Teismann P
    Exp Neurol; 2012 Jun; 235(2):528-38. PubMed ID: 22417924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
    Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent.
    Chiang MC; Cheng YC; Nicol CJ; Lin CH
    Int J Biochem Cell Biol; 2017 Nov; 92():121-133. PubMed ID: 28964868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
    Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
    Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection.
    Thouennon E; Cheng Y; Falahatian V; Cawley NX; Loh YP
    J Neurochem; 2015 Aug; 134(3):463-70. PubMed ID: 25940785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.
    Wu SH; Liao PY; Yin PL; Zhang YM; Dong L
    Am J Pathol; 2009 Jan; 174(1):115-22. PubMed ID: 19095947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.
    Yin Y; Hou G; Li E; Wang Q; Kang J
    Respir Res; 2014 Mar; 15(1):28. PubMed ID: 24612634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.
    Ji Y; Liu J; Wang Z; Li Z
    Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.